Impact of Total Arterial Grafting on Medium-Term Outcomes in CABG
Author Information
Author(s): Légaré Jean-Francois, Hassan Ansar, Buth Karen J, Sullivan John A
Primary Institution: Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia, Canada
Hypothesis
Does total arterial grafting (TAG) improve medium-term outcomes compared to conventional grafting methods?
Conclusion
Patients undergoing TAG experience lower rates of medium-term all-cause mortality and readmission to hospital for cardiac reasons compared to those undergoing LIMA+SVG, but this difference does not persist after adjusting for clinical variables.
Supporting Evidence
- TAG patients had a lower total mortality rate of 8% compared to 19% in LIMA+SVG patients.
- 29% of TAG patients were readmitted for cardiac reasons compared to 38% of LIMA+SVG patients.
- Unadjusted in-hospital mortality was 1.5% for TAG patients versus 2.0% for LIMA+SVG.
Takeaway
Using all arterial grafts for heart surgery can help patients stay healthier for a while, but when doctors consider other health factors, the benefits might not be as clear.
Methodology
Patients undergoing isolated CABG were divided into two groups based on grafting strategy: TAG or LIMA+SVG, with data collected from 1995 to 2005.
Potential Biases
Potential bias due to the non-randomized design and differences in patient characteristics between groups.
Limitations
The follow-up period may be insufficient to fully assess long-term outcomes, and the study's retrospective nature may introduce bias.
Participant Demographics
Patients included were first-time CABG patients, with TAG patients being younger and having fewer comorbidities compared to LIMA+SVG patients.
Statistical Information
P-Value
0.31
Confidence Interval
0.71–1.18
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website